129 related articles for article (PubMed ID: 36588856)
1. Utility of serum homocysteine in oral squamous cell carcinoma patients as a potential biomarker.
Palaskar S; Joshi K; Mukkanwar R; Pawar R; Kulkarni G; Pawar S
J Oral Maxillofac Pathol; 2022; 26(3):335-339. PubMed ID: 36588856
[TBL] [Abstract][Full Text] [Related]
2. Clinical Utility of Serum Homocysteine and Folate as Tumor Markers in Oral Squamous Cell Carcinoma - A Cross-Sectional Study.
Erugula SR; Kandukuri MK; Danappanavar PM; Ealla KK; Velidandla S; Manikya S
J Clin Diagn Res; 2016 Oct; 10(10):ZC24-ZC28. PubMed ID: 27891452
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H
Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386
[TBL] [Abstract][Full Text] [Related]
4. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
5. MiRNAs as non-invasive biomarkers in the serum of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorder (OPMD) patients.
Mazumder S; Basu B; Ray JG; Chatterjee R
Arch Oral Biol; 2023 Mar; 147():105627. PubMed ID: 36657275
[TBL] [Abstract][Full Text] [Related]
6. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of soluble TIM-3 in oral squamous cell carcinoma.
Lu K; Ma H; Wang T; Huang Y; Ru M
Future Oncol; 2022 Jan; ():. PubMed ID: 35051343
[TBL] [Abstract][Full Text] [Related]
8. Utility of serum and salivary lactate dehydrogenase and uric acid levels as a diagnostic profile in oral squamous cell carcinoma patients.
Anitha G; Kumar KV; Deshpande G; Nagaraj M; Kalyani V
J Oral Maxillofac Pathol; 2022; 26(2):218-227. PubMed ID: 35968187
[TBL] [Abstract][Full Text] [Related]
9. Role of Oncofetal Protein CR-1 as a Potential Tumor Marker for Oral Squamous Cell Carcinoma.
Jain A; Mallupattu SK; Thakur R; Mohindra S; Bal A; Das A; Ghoshal S; Pal A
Indian J Clin Biochem; 2021 Jul; 36(3):288-295. PubMed ID: 34220003
[TBL] [Abstract][Full Text] [Related]
10. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer.
Zanotti L; Paderno A; Piazza C; Pagan E; Bignotti E; Romani C; Bandiera E; Calza S; Del Bon F; Nicolai P; Ravaggi A
Laryngoscope; 2017 Nov; 127(11):E408-E414. PubMed ID: 28782189
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma.
Yuan C; Yang K; Tang H; Chen D
Onco Targets Ther; 2016; 9():3381-6. PubMed ID: 27350753
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
14. Midkine as a prognostic biomarker in oral squamous cell carcinoma.
Ota K; Fujimori H; Ueda M; Shiniriki S; Kudo M; Jono H; Fukuyoshi Y; Yamamoto Y; Sugiuchi H; Iwase H; Shinohara M; Ando Y
Br J Cancer; 2008 Aug; 99(4):655-62. PubMed ID: 18682710
[TBL] [Abstract][Full Text] [Related]
15. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
[TBL] [Abstract][Full Text] [Related]
16. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
[TBL] [Abstract][Full Text] [Related]
17. To evaluate an association between prognostic significance of Moesin with histopathological grading of oral squamous cell carcinoma: A systematic review.
Bommanavar S; Kanetkar SR; Datkhile KD
J Oral Maxillofac Pathol; 2023; 27(1):148-161. PubMed ID: 37234334
[TBL] [Abstract][Full Text] [Related]
18. Serum Annexin A2 Level Is Associated With Diagnosis and Prognosis in Patients With Oral Squamous Cell Carcinoma.
Zhang W; Gao C; Zhang S; Fang G
J Oral Maxillofac Surg; 2017 May; 75(5):1081-1087. PubMed ID: 27889534
[TBL] [Abstract][Full Text] [Related]
19. Assessment of biochemical factors in blood serum of patients with oral squamous cell carcinoma.
Keshani F; Mahmoodi A; Gholami M; Azmoudeh F
Dent Res J (Isfahan); 2023; 20():81. PubMed ID: 37674571
[TBL] [Abstract][Full Text] [Related]
20. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
Xie J; Li Y; Kong J; Li C
J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
